biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by bfwon Nov 21, 2018 7:27pm

78 Views

Post# 29007608

RE:RE:RE:Questions...

Wow...I’ve not had the pleasure of discussing this stock with you.

You think that I’m ignorant? You think I’m not a supporter?

I’m unclear how you come to either conclusion from what I’ve posted on this forum.

I support the current team (with my cash directly injected in to the coffers) but still believe that the latest NR could have been worded better.

bfw

OttawaPeter wrote:
You have absolutely no idea what you are talking about, MineDigger. Why would Bioasis update the boilerplate based on one study, this soon? The findings about penetrating the lymphatic system are amazing and so is the peripheral distribution, but they’d be stupid to jump the gun so soon. They were smart to secure the IP, announce it and disclose that they will explore this as an opportunity. Are you missing the point that it will very likely attract additional potential business development partners?

How much stock do you actually own, MineDigger? Any? Or are you one of those jerks like that Tailwinds guys that says he owns a lot of stock and says he buys it, but we have no way of knowing if he does.. Many people claim to own a significant amount of shares when the share price is up and claim to be buying when the share price is down, but if that were actually true, the Bioasis volume would be MUCH higher.

If you do own even a handful of shares, why the hell are you bashing the company, rather than pumping up your investment when there is this amazing news? You are the one who has no wit and clearly no idea about strategy.

We have a world-class team working for us at Bioasis, a world-renowned Scientific Advisory Board and an impressive Board of Directors. They ARE dedicated and they have accomplished more in the last 12 months than the previous management team did in 10 years. All of this despite what they inherited with the TSX venture exchange. This team set a strategy and are delivering on it. Biotech is a long game, man. Get on the bandwagon or get out, you MineDiggers, bfws, and Tailwinds of the world. We don’t need your truly ignorant comments and negativity.